KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exelixis (EXEL) Current Deferred Revenue (2016 - 2023)

Exelixis has reported Current Deferred Revenue over the past 14 years, most recently at $13.5 million for Q2 2023.

  • Quarterly results put Current Deferred Revenue at $13.5 million for Q2 2023, down 8.13% from a year ago — trailing twelve months through Jun 2023 was $13.5 million (down 8.13% YoY), and the annual figure for FY2022 was $14.1 million, down 15.0%.
  • Current Deferred Revenue for Q2 2023 was $13.5 million at Exelixis, up from $13.4 million in the prior quarter.
  • Over the last five years, Current Deferred Revenue for EXEL hit a ceiling of $19.0 million in Q2 2021 and a floor of $321000.0 in Q2 2019.
  • Median Current Deferred Revenue over the past 5 years was $13.8 million (2022), compared with a mean of $12.1 million.
  • Biggest five-year swings in Current Deferred Revenue: tumbled 94.6% in 2019 and later surged 4977.88% in 2020.
  • Exelixis' Current Deferred Revenue stood at $8.2 million in 2019, then grew by 29.27% to $10.6 million in 2020, then surged by 56.16% to $16.6 million in 2021, then decreased by 15.0% to $14.1 million in 2022, then decreased by 3.87% to $13.5 million in 2023.
  • The last three reported values for Current Deferred Revenue were $13.5 million (Q2 2023), $13.4 million (Q1 2023), and $14.1 million (Q4 2022) per Business Quant data.